Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis.

Deegens JK, Dijkman HB, Borm GF, Steenbergen EJ, van den Berg JG, Weening JJ, Wetzels JF.

Kidney Int. 2008 Dec;74(12):1568-76. doi: 10.1038/ki.2008.413. Epub 2008 Aug 27.

2.

Epithelial cell foot process effacement in podocytes in focal and segmental glomerulosclerosis: a quantitative analysis.

Kfoury H.

Ultrastruct Pathol. 2014 Oct;38(5):303-8. doi: 10.3109/01913123.2014.927405. Epub 2014 Jun 23.

PMID:
24956069
3.

Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.

Taneda S, Honda K, Ohno M, Uchida K, Nitta K, Oda H.

Virchows Arch. 2015 Oct;467(4):449-58. doi: 10.1007/s00428-015-1821-9. Epub 2015 Aug 13.

4.

Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies.

van den Berg JG, van den Bergh Weerman MA, Assmann KJ, Weening JJ, Florquin S.

Kidney Int. 2004 Nov;66(5):1901-6.

5.

Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.

Miura K, Kurihara H, Horita S, Chikamoto H, Hattori M, Harita Y, Tsurumi H, Kajiho Y, Sawada Y, Sasaki S, Igarashi T, Kunishima S, Sekine T.

Nephrol Dial Transplant. 2013 Dec;28(12):2993-3003. doi: 10.1093/ndt/gft350. Epub 2013 Sep 15.

PMID:
24042022
6.

Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.

Chang JW, Pardo V, Sageshima J, Chen L, Tsai HL, Reiser J, Wei C, Ciancio G, Burke GW 3rd, Fornoni A.

Transplantation. 2012 Jun 27;93(12):1238-44. doi: 10.1097/TP.0b013e318250234a.

7.

Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.

Sethi S, Glassock RJ, Fervenza FC.

Nephrol Dial Transplant. 2015 Mar;30(3):375-84. doi: 10.1093/ndt/gfu035. Epub 2014 Mar 2. Review.

PMID:
24589721
8.

Low birthweight and premature birth are risk factors for podocytopenia and focal segmental glomerulosclerosis.

Ikezumi Y, Suzuki T, Karasawa T, Yamada T, Hasegawa H, Nishimura H, Uchiyama M.

Am J Nephrol. 2013;38(2):149-57. doi: 10.1159/000353898. Epub 2013 Aug 6.

PMID:
23920104
9.

Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.

Fatima H, Moeller MJ, Smeets B, Yang HC, D'Agati VD, Alpers CE, Fogo AB.

Clin J Am Soc Nephrol. 2012 Nov;7(11):1852-8. doi: 10.2215/CJN.10571011. Epub 2012 Aug 23.

10.

[The clinic significance of urinary podocytes in patients with focal segmental glomerulosclerosis].

Li YH, Huang HC, Liu G, Zhang YK.

Beijing Da Xue Xue Bao. 2004 Apr;36(2):135-8. Chinese.

11.

Ultrastructural features and expression of cytoskeleton proteins of podocyte from patients with minimal change disease and focal segmental glomerulosclerosis.

Shi SF, Wang SX, Zhang YK, Zhao MH, Zou WZ.

Ren Fail. 2008;30(5):477-83. doi: 10.1080/08860220802060497.

PMID:
18569926
12.

Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.

Kim JS, Han BG, Choi SO, Cha SK.

Biomed Res Int. 2016;2016:1630365. doi: 10.1155/2016/1630365. Epub 2016 Mar 21. Review.

13.

The urinary podocyte as a marker for the differential diagnosis of idiopathic focal glomerulosclerosis and minimal-change nephrotic syndrome.

Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H.

Am J Nephrol. 2000 May-Jun;20(3):175-9.

PMID:
10878397
14.
15.

Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.

Alachkar N, Wei C, Arend LJ, Jackson AM, Racusen LC, Fornoni A, Burke G, Rabb H, Kakkad K, Reiser J, Estrella MM.

Transplantation. 2013 Oct 15;96(7):649-56. doi: 10.1097/TP.0b013e31829eda4f.

16.

Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.

Eriguchi M, Yotsueda R, Torisu K, Kawai Y, Hasegawa S, Tanaka S, Noguchi H, Masutani K, Kitazono T, Tsuruya K.

Am J Physiol Renal Physiol. 2016 Feb 15;310(4):F322-33. doi: 10.1152/ajprenal.00260.2015. Epub 2015 Dec 2.

18.
19.

[Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].

Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Salcedo MT.

Nefrologia. 2014;34(1):53-61. doi: 10.3265/Nefrologia.pre2013.Oct.12272. Spanish.

20.

Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?

Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F335-41. doi: 10.1152/ajprenal.00510.2015. Epub 2015 Dec 23.

Supplemental Content

Support Center